Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events
Status:
Unknown status
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
This multi-center, randomized controlled study aims to evaluate the efficacy of Cilostazol
versus Aspirin for primary prevention of atherosclerotic events with Korean type 2 Diabetes
Mellitus (DM) patients.
Phase:
Phase 4
Details
Lead Sponsor:
Hanyang University
Collaborators:
Ajou University School of Medicine Hallym University Medical Center Inha University Hospital Inje University Korea University Guro Hospital Kyunghee University Medical Center